OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Advantages of the Combinatorial Molecular Targeted Therapy of Head and Neck Cancer—A Step before Anakoinosis-Based Personalized Treatment
Robert Kleszcz
Cancers (2023) Vol. 15, Iss. 17, pp. 4247-4247
Open Access | Times Cited: 6
Robert Kleszcz
Cancers (2023) Vol. 15, Iss. 17, pp. 4247-4247
Open Access | Times Cited: 6
Showing 6 citing articles:
Therapeutic Effect of Cisplatin-Loaded Polymeric Nanoparticles and Nimotuzumab Combination in Human Glioblastoma Cells
Elif Kağa, Serhat Korkmaz, Sadık Kağa
Research Square (Research Square) (2025)
Closed Access
Elif Kağa, Serhat Korkmaz, Sadık Kağa
Research Square (Research Square) (2025)
Closed Access
Epithelial‑derived head and neck squamous tumourigenesis (Review)
Charles Shirima, Coralia Bleoţu, Demetrios�� Spandidos, et al.
Oncology Reports (2024) Vol. 52, Iss. 4
Closed Access | Times Cited: 2
Charles Shirima, Coralia Bleoţu, Demetrios�� Spandidos, et al.
Oncology Reports (2024) Vol. 52, Iss. 4
Closed Access | Times Cited: 2
Peroxisome proliferator-activated receptorα/γ agonist pioglitazone for rescuing relapsed or refractory neoplasias by unlocking phenotypic plasticity
Dennis Christoph Harrer, Florian Lüke, Tobias Pukrop, et al.
Frontiers in Oncology (2024) Vol. 13
Open Access
Dennis Christoph Harrer, Florian Lüke, Tobias Pukrop, et al.
Frontiers in Oncology (2024) Vol. 13
Open Access
Evaluation of Five-year Overall Survival Rates Among 18,331 Head and Neck Cancer Patients Exposed to Different Targeted Therapies Through Real-world Data in a Case-controlled Study
JOSEFINE BAUDREXL, Andreas Sakkas, Sebastian Pietzka, et al.
Anticancer Research (2024) Vol. 44, Iss. 3, pp. 1247-1270
Open Access
JOSEFINE BAUDREXL, Andreas Sakkas, Sebastian Pietzka, et al.
Anticancer Research (2024) Vol. 44, Iss. 3, pp. 1247-1270
Open Access
Chloride intracellular channels in oncology as potential novel biomarkers and personalized therapy targets: a systematic review
Bartosz Wojtera, Kamila Ostrowska, Mateusz Szewczyk, et al.
Reports of Practical Oncology & Radiotherapy (2024)
Open Access
Bartosz Wojtera, Kamila Ostrowska, Mateusz Szewczyk, et al.
Reports of Practical Oncology & Radiotherapy (2024)
Open Access
PRI-724 and IWP-O1 Wnt Signaling Pathway Inhibitors Modulate the Expression of Glycolytic Enzymes in Tongue Cancer Cell Lines
Robert Kleszcz, Jarosław Paluszczak, Marta Belka, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 12, pp. 9579-9592
Open Access | Times Cited: 1
Robert Kleszcz, Jarosław Paluszczak, Marta Belka, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 12, pp. 9579-9592
Open Access | Times Cited: 1
